Savings & offers for ANORO ELLIPTA

Sign up to see if you're eligible to pay no more than $10 a month for ANORO for 12 months.*

By signing up, you'll also receive tips and information for getting the most out of treatment with ANORO.

Things to know about this offer:

  • Read Full Requirements and Restrictions. Subject to eligibility. Restrictions apply.
    • Eligible commercially insured patients pay no more than $10 per 30-day supply of ANORO.
    • This offer is valid for up to 12 uses, and each 30-day supply counts as 1 use.
    • Eligible patients without insurance to cover the cost of their prescription will receive up to $100 in savings on each 30-day supply of ANORO. You will be responsible for any remaining out-of-pocket cost.
  • This is NOT health insurance.
  • Keep this coupon. It can be used once per month for up to 12 months prior to the expiration date.
  • Coupon should be presented to your pharmacist for each refill.

*Subject to eligibility. Restrictions apply.

Program Enrollment:

Indicates required field.
Which of the following statements best describes you?
Has your doctor prescribed ANORO?
Are you currently treating your COPD with ANORO?
Are you enrolled in any state-, federal-, or government-funded medical or prescription benefit program, including but not limited to Medicare, Medicaid, Medigap, VA, DOD, TRICARE®, or CHAMPUS?

TRICARE® is a registered trademark of the Department of Defense. All rights reserved.

Do you have health insurance that covers prescription drugs?

Program Enrollment:

GSK believes your privacy is important. By providing your name, address, e-mail address, and other information, you are giving GSK and companies working with GSK permission to market or advertise to you regarding the medical condition(s) in which you have expressed an interest, as well as other general health-related information from GSK. GSK will not sell or transfer your name or e-mail address to any other party for their own marketing use.

For additional information regarding how GSK handles your information, please see our privacy statement.

Savings Offer Consent:

I'd like to receive savings offers on my prescription. I understand by selecting "I agree" below, that I am agreeing GSK and companies working with GSK (for example, the program administrator) can use the personal information I provide when I enroll, as well as information received from my pharmacy about my use of the savings offer and the date on which I filled my prescription. GSK and the program administrator have my consent to use the information to select additional mailings and offers that may be of interest to me in connection with this program. I understand that I can revoke this authorization at any time by contacting GSK at 1-888-825-5249 or https://www.contactus.gsk.com/optout/index.html, and that even if I decide not to participate in this GSK offer, it will not impact my ability to receive treatment from my healthcare provider.

In order to join this program and be eligible for the savings offer, you must agree to the Savings Offer Consent above. If you would like to change your answer, please select "I agree to the Savings Offer Consent."


Once-daily ANORO is a prescription medicine used long term to treat COPD for better breathing. ANORO is not used to treat sudden COPD symptoms and won't replace a rescue inhaler. ANORO is not for asthma.

IMPORTANT SAFETY INFORMATION FOR ANORO ELLIPTA

  • ANORO is only approved for use in COPD. ANORO is NOT approved for use in asthma.
  • People with asthma who take long-acting beta2-adrenergic agonist (LABA) medicines, such as vilanterol (one of the medicines in ANORO), have an increased risk of death from asthma problems. It is not known if LABA medicines increase the risk of death in people with COPD.

IMPORTANT SAFETY INFORMATION FOR ANORO ELLIPTA

  • ANORO is only approved for use in COPD. ANORO is NOT approved for use in asthma.
  • People with asthma who take long-acting beta2-adrenergic agonist (LABA) medicines, such as vilanterol (one of the medicines in ANORO), have an increased risk of death from asthma problems. It is not known if LABA medicines increase the risk of death in people with COPD.
  • Call your healthcare provider if breathing problems worsen over time while using ANORO.
  • Get emergency medical care if your breathing problems worsen quickly or if you use your rescue inhaler but it does not relieve your breathing problems.
  • Do not use ANORO to treat sudden breathing problems. Always have a rescue inhaler with you to treat sudden symptoms.
  • ANORO is not for the treatment of asthma. It is not known if ANORO is safe and effective in people with asthma.
  • Do not use ANORO if you have a severe allergy to milk proteins or any of the ingredients in ANORO. Ask your healthcare provider if you are not sure.
  • Do not use ANORO more often than prescribed.
  • Do not take ANORO with other medicines that contain a LABA or an anticholinergic for any reason. Tell your healthcare provider about all the medicines you take and about all of your health conditions. Especially tell your healthcare provider if you take anticholinergics, including tiotropium, ipratropium, aclidinium, or atropine.
  • ANORO can cause serious side effects, including:
    • sudden breathing problems immediately after inhaling your medicine. If you have sudden breathing problems immediately after inhaling your medicine, stop using ANORO and call your healthcare provider right away.
    • serious allergic reactions. Call your healthcare provider or get emergency medical care if you get any of the following symptoms of a serious allergic reaction:
      • rash
      • hives
      • swelling of your face, mouth, and tongue
      • breathing problems
    • effects on heart
      • increased blood pressure
      • a fast or irregular heartbeat, awareness of heartbeat
      • chest pain
    • effects on nervous system
      • tremor
      • nervousness
    • new or worsened eye problems, including acute narrow-angle glaucoma. Acute narrow-angle glaucoma can cause permanent loss of vision if not treated. Symptoms of acute narrow-angle glaucoma may include:
      • eye pain or discomfort
      • nausea or vomiting
      • blurred vision
      • seeing halos or bright colors around lights
      • red eyes

      If you have these symptoms, call your healthcare provider right away before taking another dose.
    • urinary retention. People who take ANORO may develop new or worse urinary retention. Symptoms of urinary retention may include:
      • difficulty urinating
      • painful urination
      • urinating frequently
      • urination in a weak stream or drips

      If you have these symptoms of urinary retention, stop taking ANORO and call your healthcare provider right away before taking another dose.
    • changes in laboratory blood levels, including high levels of blood sugar (hyperglycemia) and low levels of potassium (hypokalemia)
  • Common side effects of ANORO include:
    • sore throat
    • sinus infection
    • lower respiratory infection
    • common cold symptoms
    • constipation
    • diarrhea
    • pain in your arms or legs
    • muscle spasms
    • neck pain
    • chest pain
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.